Skip to main content
Equibles

MILLENNIUM MANAGEMENT LLC

Position in LNTH — Lantheus Holdings, Inc.

CIK 1273087 NEW YORK, NY
Back to LNTH Full portfolio

Position in LNTH

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$19,359,726
+$7,777,165 QoQ
Shares Held
255,237
+46.7% QoQ
Ownership
0.392%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
22 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in LNTH Over Time

Shares Held

Position Value (USD)

Derivatives in LNTH

reported options exposure · as of Jun 30, 2025
CallValue
$4,191,232
CallShares
51,200
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

MILLENNIUM MANAGEMENT LLC holds $1,135,897,995 across 44 Drug Manufacturers - Specialty & Generic names. LNTH ranks #11 (1.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 1,649,955 $195,041,180
2 SUPN
Supernus Pharmaceuticals, Inc.
 3,315,973 $171,402,644
3 NBIX
Neurocrine Biosciences Inc
 1,247,447 $164,338,667
4 INDV
Indivior Pharmaceuticals, Inc.
 4,595,535 $140,071,906
5 UTHR
UNITED THERAPEUTICS Corp
 153,372 $90,946,528
6 TEVA
Teva Pharmaceutical Industries Ltd
 1,893,845 $57,042,611
7 PRGO
PERRIGO Co plc
 4,279,731 $45,964,310
8 ANIP
Ani Pharmaceuticals Inc
 592,013 $45,525,799

All Filings in LNTH

Export CSV
45 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $19,359,726 255,237
2025-12-31 $11,582,561 174,043
2025-09-30 $22,745,371 443,466
2025-06-30 $7,548,228 92,209
2025-06-30 $4,191,232 51,200
2025-03-31 $497,760 5,100
2025-03-31 $9,332,512 95,620
2024-12-31 $527,814 5,900
2024-12-31 $432,002 4,829
2024-09-30 $647,525 5,900
2024-09-30 $24,570,391 223,876
2024-06-30 $3,813,775 47,500
2024-06-30 $59,964,747 746,852
2024-06-30 $15,190,868 189,200
2024-03-31 $56,789,518 912,428
2024-03-31 $2,794,576 44,900
2024-03-31 $1,114,096 17,900
2023-12-31 $10,145,494 163,637
2023-12-31 $2,647,400 42,700
2023-12-31 $1,252,400 20,200
2023-09-30 $3,474,000 50,000
2023-09-30 $1,389,600 20,000
2023-09-30 $65,051,622 936,264
2023-06-30 $91,228,676 1,087,091
2023-06-30 $4,196,000 50,000
2023-03-31 $20,518,141 248,524
2022-12-31 $1,783,600 35,000
2022-12-31 $77,646,172 1,523,669
2022-09-30 $39,488,536 561,475
2022-06-30 $3,301,500 50,000
2022-06-30 $120,334,788 1,822,426
2022-03-31 $1,659,300 30,000
2022-03-31 $92,828,708 1,678,335
2022-03-31 $829,650 15,000
2021-12-31 $4,333,500 150,000
2021-12-31 $55,765,673 1,930,276
2021-12-31 $4,044,600 140,000
2021-09-30 $3,852,000 150,000
2021-09-30 $52,091,931 2,028,502
2021-06-30 $5,528,000 200,000
2021-06-30 $59,313,201 2,145,919
2021-06-30 $5,804,400 210,000
2021-03-31 $1,068,500 50,000
2021-03-31 $19,446,251 909,979
2020-06-30 $716,959 50,137

Report a Problem

Category
Description
Email (optional, for follow-up)